Status:
COMPLETED
Selenoprotein P and Non-alcoholic Fatty Liver Disease
Lead Sponsor:
Korea University
Conditions:
Non-alcoholic Fatty Liver Disease
Insulin Resistance
Eligibility:
All Genders
20-80 years
Brief Summary
The pathogenesis of nonalcoholic fatty liver disease has not been fully elucidated. The most widely supported theory implicates insulin resistance as the key mechanism leading to hepatic steatosis, an...
Detailed Description
Nonalcoholic fatty liver disease (NAFLD), a disease spectrum that includes simple steatosis, nonalcoholic steatohepatitis (NASH) and cirrhosis, has been increasingly recognized as the hepatic manifest...
Eligibility Criteria
Inclusion
- Healthy volunteers for visiting routine medical check in our clinic
Exclusion
- History of cardiovascular disease(myocardial infarction, unstable angina, or cardiovascular revascularization)
- Diabetes
- Hypertension
- Malignancy
- Severe renal or hepatic disease
- Subjects taking medications that might affect body weight or body composition
Key Trial Info
Start Date :
September 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01257685
Start Date
September 1 2007
End Date
August 1 2008
Last Update
September 3 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hae Yoon Choi
Seoul, South Korea, 152-703